AU588339B2 - Culture media for in vitro fertilization and embryo transfer - Google Patents
Culture media for in vitro fertilization and embryo transferInfo
- Publication number
- AU588339B2 AU588339B2 AU59696/86A AU5969686A AU588339B2 AU 588339 B2 AU588339 B2 AU 588339B2 AU 59696/86 A AU59696/86 A AU 59696/86A AU 5969686 A AU5969686 A AU 5969686A AU 588339 B2 AU588339 B2 AU 588339B2
- Authority
- AU
- Australia
- Prior art keywords
- sodium
- potassium
- culture medium
- chloride
- ions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000001963 growth medium Substances 0.000 title claims description 30
- 230000004720 fertilization Effects 0.000 title claims description 17
- 238000000338 in vitro Methods 0.000 title claims description 15
- 210000001161 mammalian embryo Anatomy 0.000 title description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 36
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 28
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 27
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 18
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 18
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 18
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 18
- 229910001415 sodium ion Inorganic materials 0.000 claims description 18
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims description 18
- 229910001414 potassium ion Inorganic materials 0.000 claims description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 13
- 210000000287 oocyte Anatomy 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 9
- 239000007836 KH2PO4 Substances 0.000 claims description 9
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 claims description 9
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 9
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 9
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 9
- 229960003531 phenolsulfonphthalein Drugs 0.000 claims description 9
- 239000001103 potassium chloride Substances 0.000 claims description 9
- 235000011164 potassium chloride Nutrition 0.000 claims description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 9
- 239000001540 sodium lactate Substances 0.000 claims description 9
- 235000011088 sodium lactate Nutrition 0.000 claims description 9
- 229940005581 sodium lactate Drugs 0.000 claims description 9
- 229940054269 sodium pyruvate Drugs 0.000 claims description 9
- 239000001110 calcium chloride Substances 0.000 claims description 8
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 8
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical group O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 229930182555 Penicillin Natural products 0.000 claims description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 4
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims description 4
- 229940049954 penicillin Drugs 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 239000012530 fluid Substances 0.000 description 20
- 239000002609 medium Substances 0.000 description 19
- 230000035935 pregnancy Effects 0.000 description 9
- 230000000977 initiatory effect Effects 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 230000013020 embryo development Effects 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 210000002257 embryonic structure Anatomy 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000002459 blastocyst Anatomy 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- BITYAPCSNKJESK-UHFFFAOYSA-N potassiosodium Chemical compound [Na].[K] BITYAPCSNKJESK-UHFFFAOYSA-N 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0609—Oocytes, oogonia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
CULTURE MEDIA FOR IN VITRO FERTILIZATION AND EMBRYO TRANSFER
The invention relates to culture media and more particularly to culture media for in vitro fertilization and embryo transfer.
The process ofi n vitro fertilization of human oocytes, cleavage of embryos and embryo transfer require that a culture medium be used to support the embryo for a period of up to three or four days during the various processes necessary for fertilization and early incubation before embryo transfer and reimplantatlon.
In the natural process of fertilization for a human oocyte the oocyte is supported within the mother within a fluid known as human tubal fluid andi t i s the object of the present invention to provide a culture medium as a synthetic human tubal fluid.
Approximation of the culture conditions as close as possible to those found in the natural environment of the gametes may be most likely to yield the best results. Using this rationale early workers have formulated a culture media similar in biochemical composition to human tubal fluid with varying rates of success. Examples of these include Tyrodes Medium T6, WM1 (Hoppe and Pitts), Modified Earles, and Hams F 10.
One important characteristic of synthetic human tubal fluids appears to the ratio of sodium ions to potassium ions. For natural human tubal fluid this valve is approximately 18. Earlier attempts such as Tyrodes Medium T6 have a value of over 100. We have found that values in between these are most advantageous.
In the present invention we have devised a synthetic culture medium which is believed to approximate human tubal fluid but with desirable additional components and variations in the actual composition, including ratios of concentrations of sodium ions to potassium ions.
In one form therefore the present invention may be said to reside in a culture medium for in vitro fertilization and embryo transfer comprising the following compounds in the following ranges of concentration;
Sodium chloride (NaCI) 96.5 - 106.7 mM Potassium chloride (KCl) 4.46 - 4.92mM
Magnesium sulphate (MgSO47H2O) 0.18 - 0.22mM
Potassium phosphate monobasic (KH2PO4) 0.35 - 0.39mM
Calcium chloride 2 hydrate (CaCl22H2O) 1.94 - 2.14mM
Sodium bicarbonate (NaHCO3) 23.7 - 26.3mM
Glucose 2.64 - 2.92mM
Sodium Pyruvate 0.31 - 0.35mM
Sodium Lactate 20.3 - 22.5mM Penicillin 95 - 105 units/m l
Phenol red 5 - 15 micrograms/m l
In a preferred embodiment of the invention, the ratio of sodium ion concentration to potassium ion concentration is in the range from 28 to 32.
In a further preferred embodiment the ratio of concentrations of sodium ions to potassium ions is 29.3.
In one preferred embodiment of the i nvention the synthetic human tubal fluid may have the following composition;
Sodium Chloride (NaCI) 101.6 mM
Potassium chloride (KCl) 4.69 mM Magnesium sulphate (MgSO47H2O) 0.20mM
Potassium phosphate monobasic (KH2PO4) 0.37mM
Calcium chloride 2 hydrate
(CaCl22H2O) 2.04mM Sodium bicarbonate (NaHCO3) 25.0mM
Glucose 2.78mM
Sodium pyruvate 0.33mM
Sodium lactate 21.4mM
Penicillin 100 units/ml
Phenol red 10 micrograms/ml
In another form the invention may be said to reside in a method of assisting with the in vitro fertilization of human oocytes including the step of handling the human oocytes in a culture medium, the culture medium being comprised of the compounds listed below in the range of compositions listed as follows;
Sodium chloride (NaCI ) 96.5 - 106.7mM
Potassium chloride (KCl ) 4.46 - 4.92mM
Magnesium sulphate (MgSO4 7H2O) 0.18 - 0.22mM
Potassium phosphate monobasic
(KH2PO4) 0.35 - 0.39mM
Calcium chloride 2 hydrate
(CaCl 2 2H2 O) 1.94 - 2.14mM
Sodium bicarbonate (NaHCO3) 23.7 - 26.3mM
Glucose 2.64 - 2.92mM
Sodium pyruvate 0.31 - 0.35mM
Sodium lactate 20.3 - 22.5mM
Penicillin 95 - 105 units/ml
Phenol red 5 - 15 micrograms/ml
In a preferred embodiment of this method of the invention, the ratio of sodium ion concentration to potassium ion concentration is in the range of from 28 to 32.
In a further preferred form of the invention, the ratio concentration of sodium ions to potassium ions is 29.3.
In a further preferred form of the invention, the method includes the step of handling the oocytes in a culture medium comprising;
Sodium Chloride (NaCI) 101.6 mM
Potassium chloride (Kcl) 4.69 mM
Magnesium sulphate (MgSO47H2O) 0.20mM
Potassium phosphate monobasic (KH2PO4) 0.37mM
Calcium chloride 2 hydrate
(CaCl22H2O) 2.04mM
Sodium bicarbonate (NaHCO3) 25.0mM
Glucose 2.78mM
Sodium pyruvate 0.33mM
Sodium lactate 21.4mM
Penicillin 100 units/ml
Phenol red 10 micrograms/ml
In a further form thei nvention may be said to reside in a culture medium for thei n vitro fertilization of human oocytesi ncluding sodium potassiumi ons wherein the ratio of sodium ions to potassium ions is i n the range of from 28 to 32.
In a preferred embodiment of this form of the invention, the ratio of sodium ions to potassium ions is 29.3.
This then generally describes the nature of the present invention and it will be seen that by this invention there is provided a culture medium which is not exactly the same as natural human tubal fluid, but which is capable of supporting in vitro fertilization.
To more clearly assist with the understanding of this invention reference will now be made to a preferred embodiment and tests to determine the efficacy of the preferred embodiment.
In one preferred embodiment synthetic human tubal fluid culture medium is as given in Table 1 below (marked synthetic HTF).
The medium may be prepared by using rainwater which has been distilled in glass six times. The bicarbonate-buffered medium is gassed for a minimum of five minutes with humidified 5% oxygen 5% carbon dioxide
90% nitrogen mixture and sterilized by passage through a 0.45-0.2 micrometre filter membrane (Millipore, Sydney, Australia or Amicon Sterilet Adelaide, Australia) and then stored at 4°C for up to two weeks before use. A minimum of six hours or preferably the day before being used the bicarbonate buffered medium is gassed again for two to three minutes with the same gas mixture as above and the protein component is added.
In a similar way a known culture medium Tyrodes Medium T6 having a composition as given in Table 1 below was also prepared.
T6 FT
l O O l . O O
100 100
Tests have been carried out using both mouse embryo development in vitro and with initiation of human pregnancy in an endeavour to discover which components of the T6 medium and the synthetic human tubal fluid according to this invention might be responsible for observed differences in mouse embryo development in vitro and initiation of human pregnancies. The results show that for human pregnancy initiation almost three times as many pregnancies occurred when fertilization and culture were carried out
using the synthetic human tubal fluid of the present invention over the T6 medium.
In comparison of the two compositions a greatest difference in composition of the two media are their Na+/K+ ratios. We refer to these as sodium/potassium for the rest of the specification.
The ratios of concentrations of sodium ions to potassium ions for these are as follows:
Synthetic Human Tubal Fluid according to the present invention - 29.3
T6 - 105
When media are tested with sodium/potassium leveis varying from 150.5/ 1.42 millimoles to 148.2/5.06 millimoles results showed that there was significant linear and quadratic responses in the number of embryos developing to expanded blastocysts with increasing levels of K+.
In medium containing the potassium levels of T6 medium 75% of the zygotes developed which was significantly fewer than the 95-100% embryos developing when the potassium level was 2.3 to 5.1 millimoles which is the range for the synthetic human tubal fluid of the present invention.
The greatest number of mouse zygotes developing to expanded blastocysts when cultured In synthetic human tubal fluid medium of the present invention compared to T6 medium was paralleled by the three fold increase of the number of pregnancies initiated in those patients whose gametes had been fertilized and cultured in the medium in the present invention rather than T6 medium.
The present invention therefore provides a synthetic human tubal fluid culture medium which is more than just a direct replication of naturally occurring human tubal fluid but has enhanced viability.
Potassium chloride (Kcl) 4.69 mM
Magnesium sulphate (MgSO47H2O) 0.20mM
Potassium phosphate monobasic (KH2PO4) 0.37mM
Calcium chloride 2 hydrate
(CaCl22H2O) 2.04mM
Sodium bicarbonate (NaHCO3) 25.0mM
Glucose 2.78mM
Sodium pyruvate 0.33mM
Sodium lactate 21.4mM
Penicillin 100 units/ml
Phenol red 10 micrograms/ml
In a further form the invention may be said to reside i n a culture medium for the in vitro fertilization of human oocytes i ncluding sodium potassium i ons wherein the ratio of sodium i ons to potassium ions i s in the range of from 28 to 32.
In a preferred embodiment of this form of the invention, the ratio of sodium ions to potassiumi ons is 29.3.
This then generally describes the nature of the present invention and it will be seen that by this invention there is provided a culture medium which i s not exactly the same as natural human tubal fluid, but which is capable of supporting in vitro fertilization.
To more clearly assist with the understanding of this invention reference will now be made to a preferred embodiment and tests to determine the efficacy of the preferred embodiment.
In one preferred embodiment synthetic human tubal fluid culture medium i s as given in Table 1 below (marked synthetic HTF).
The medium may be prepared by using rainwater which has been distilled in glass six times. The bicarbonate-buffered medium is gassed for a minimum of five minutes with humidified 5% oxygen 5% carbon dioxide
90% nitrogen mixture and sterilized by passage through a 0.45-0.2 micrometre filter membrane (Millipore, Sydney, Australia or Amlcon Sterilet Adelaide, Australia) and then stored at 4°C for up to two weeks before use. A minimum of six hours or preferably the day before being used the bicarbonate buffered medium is gassed again for two to three minutes with the same gas mixture as above and the protein component is added.
In a similar way a known culture medium Tyrodes Medium T6 having a composition as given in Table 1 below was also prepared.
T6
HFT
l O O O . O O
100 100
Tests have been carried out using both mouse embryo development in vitro and with initiation of human pregnancy in an endeavour to discover which components of the T6 medium and the synthetic human tubal fluid according to this invention might be responsible for observed differences in mouse embryo development in vitro and initiation of human pregnancies. The results show that for human pregnancy initiation almost three times as many pregnancies occurred when fertilization and culture were carried out
Claims (10)
1. A culture medium for in vitro fertilization of human oocytes comprising:
Sodium chloride (NaCI) 96.5 - 106.7 mM Potassium chloride (KCl) 4.46 - 4.92mM Magnesium sulphate (MgSO47H2O) 0.18 - 0.22mM
Potassium phosphate monobasic (KH2PO4) 0.35 - 0.39mM
Calcium chloride 2 hydrate (CaCl22H2O) 1.94 - 2.14mM
Sodium bicarbonate (NaHCO3) 23.7 - 26.3mM
Glucose 2.64 - 2.92mM
Sodium Pyruvate 0.31 - 0.35mM
Sodium Lactate 20.3 - 22.5mM
Penicillin 95 - 105 units/m l
Phenol red 5 - 15 micrograms/m l
2. A culture medium in Claim 1 wherein the ratio of sodium ion concentration to potassium ion concentration is in the range of from 28 to 32.
3. A culture medium as in Claim 2 wherein the ratio of concentrations of sodium ions to potassium ions is approximately 29.3.
4. A culture medium as in Claim 1 comprising approximately;
Sodium Chloride (NaCI) 101.6 mM Potassium chloride (KCl) 469 mM Magnesium sulphate (MgSO47H2O) 0.20mM
Potassium phosphate monobasic (KH2PO4) 0.37mM
Calcium chloride 2 hydrate
(CaCl22H2O) 2.04mM Sodium bicarbonate (NaHCO3) 25.0mM Glucose 2.78 mM Sodium pyruvate 0.33mM Sodium lactate 21.4mM
Penicillin 100 units/ml
Phenol red 10 micrograms/ml
5. A method of assisting with the in vitro fertilization of human oocytes including the steps of handling the oocytes in a culture medium, the culture medium being of the compounds being listed below in the range of compositions as follows;
Sodium chloride (NaCI) 96.5 - 106.7 mM
Potassium chloride (KCl) 4.46 - 4.92mM
Magnesium sulphate (MgSO47H2O) 0.18 - 0.22mM
Potassium phosphate monobasic (KH2PO4) 0.35 - 0.39mM Calcium chloride 2 hydrate
(CaCl22H2O) 1.94 - 2.14mM
Sodium bicarbonate (NaHCO3) 23.7 - 26.3mM
Glucose 2.64 - 2.92mM
Sodium Pyruvate 0.31 - 0.35mM Sodium Lactate 20.3 - 22.5mM
Penicillin 95 - 105 units/m l
Phenol red 5 - 15 micrograms/m l
6. A method as in Claim 5 wherein the ratio of sodium ion concentration to potassium ion concentration is in the range of from 28 to 32.
7. A method as in Claim 6 wherein the ratio of concentration of sodium ions to potassium ions is approximately 29.3.
8. A method as in Claim 5 wherein the culture medium has a concentration as follows;
Sodium Chloride (NaCI) 101.6 mM
Potassium chloride (Kcl) 4.69 mM Magnesium sulphate (MgSO47H2O) 0.20mM
Potassium phosphate monobasic (KH2PO4) 0.37mM Calcium chloride 2 hydrate
(CaCl22H2O) 2.04mM Sodium bicarbonate (NaHCO3) 25.0mM Glucose 2.78mM
Sodium pyruvate 0.33mM Sodium lactate 21.4mM Penicillin 100 units/ml Phenol red 10 micrograms/ml
9. A culture medium for the in vitro fertilization of human oocytes including sodium and potassium ions wherein the ratio of sodium ions to potassium ions is in the range of from 28 to 32.
10. A culture medium as in Claim 9 wherein the ratio of sodium Ions to potassium ions is approximately 29.3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU59696/86A AU588339B2 (en) | 1985-06-12 | 1986-06-12 | Culture media for in vitro fertilization and embryo transfer |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPH100985 | 1985-06-12 | ||
| AUPH1009 | 1985-06-12 | ||
| AU59696/86A AU588339B2 (en) | 1985-06-12 | 1986-06-12 | Culture media for in vitro fertilization and embryo transfer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU5969686A AU5969686A (en) | 1987-01-07 |
| AU588339B2 true AU588339B2 (en) | 1989-09-14 |
Family
ID=25632544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU59696/86A Ceased AU588339B2 (en) | 1985-06-12 | 1986-06-12 | Culture media for in vitro fertilization and embryo transfer |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU588339B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU628796B2 (en) * | 1987-12-30 | 1992-09-24 | W.R. Grace & Co.-Conn. | In vitro culture of bovine embryos |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3128228A (en) * | 1960-03-04 | 1964-04-07 | Ustav Ser A Ockovacich Latek | Tissue culture medium |
| AU8338082A (en) * | 1981-02-27 | 1982-09-14 | Amf Inc. | Tissue culture medium |
| AU8853282A (en) * | 1981-10-05 | 1983-04-14 | Alcon Laboratories, Inc. | Opthalmic irrigating solution |
-
1986
- 1986-06-12 AU AU59696/86A patent/AU588339B2/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3128228A (en) * | 1960-03-04 | 1964-04-07 | Ustav Ser A Ockovacich Latek | Tissue culture medium |
| AU8338082A (en) * | 1981-02-27 | 1982-09-14 | Amf Inc. | Tissue culture medium |
| AU8853282A (en) * | 1981-10-05 | 1983-04-14 | Alcon Laboratories, Inc. | Opthalmic irrigating solution |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU628796B2 (en) * | 1987-12-30 | 1992-09-24 | W.R. Grace & Co.-Conn. | In vitro culture of bovine embryos |
Also Published As
| Publication number | Publication date |
|---|---|
| AU5969686A (en) | 1987-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Whitten | Nutrient requirements for the culture of preimplantation embryos in vitro | |
| Boatman | In vitro growth of non-human primate pre-and peri-implantation embryos | |
| Wiley et al. | Effect of potassium concentration, type of protein supplement, and embryo density on mouse preimplantation development in vitro | |
| Lewontin | The units of selection | |
| Fabiani et al. | Enhanced recruitment of motile spermatozoa by prostasome inclusion in swim-up medium | |
| Wright Jr et al. | Successful culture in vitro of bovine embryos to the blastocyst stage | |
| Kane | In vitro growth of preimplantation rabbit embryos | |
| Keefer et al. | Spontaneous activation of ovulated rat oocytes during in vitro culture | |
| MAHI et al. | The effects of temperature, osmolality and hydrogen ion concentration on the activation and acrosome reaction of golden hamster spermatozoa | |
| Deusser et al. | Biological sciences: ribosomal proteins: variation of the protein composition in Escherichia coli ribosomes as function of growth rate | |
| KR880700064A (en) | Rubber polymerase and its preparation and use | |
| JP4202121B2 (en) | Mammalian gamete and embryo culture supplements and uses thereof | |
| WO1986007377A1 (en) | Culture media for in vitro fertilization and embryo transfer | |
| CN111073848A (en) | Cleavage stage embryo culture composition and cleavage stage embryo culture solution | |
| Fildes et al. | The nitrogen and vitamin requirements of B. typhosus | |
| AU588339B2 (en) | Culture media for in vitro fertilization and embryo transfer | |
| EP2790499B1 (en) | Culture media for treating female gametes and embryos in medically assisted reproduction techniques | |
| Karn | Sexual and asexual differentiation in Volvox obversus (Shaw) Printz, strains Wd3 and Wd7 | |
| Spindle | In vitro development of one-cell embryos from outbred mice: influence of culture medium composition | |
| Mahadevan et al. | Growth of mouse embryos in bicarbonate media buffered by carbon dioxide, hepes, or phosphate | |
| Ray et al. | G6PD expression and X chromosome late replication in fibroblast clones from a female mule | |
| Trager et al. | The chemical nature of growth factors required by Mosquito Larvæ: I. Riboflavin And Thiamin | |
| Liu et al. | The effect of serum on motility of human spermatozoa in culture | |
| Bavister et al. | Alteration of extracellular cation concentrations and ratios in culture medium does not affect first cleavage division of hamster zygotes in vitro nor overcome the'two-cell block' | |
| Kleeman et al. | Observed differences in CO2 requirements between mammalian and salmonid fish cell lines |